667462-10-4

Basic information

• Product Name: 2-(PIPERAZIN-1-YL)-ACETIC ACID N-(3-PYRIDYL)-AMIDE 3 HCL
• Synonyms: 2-(PIPERAZIN-1-YL)-ACETIC ACID N-(3-PYRIDYL)-AMIDE 3 HCL;2-(PIPERAZIN-1-YL)ACETIC ACID N-(3-PYRIDYL)AMIDE TRIHYDROCHLORIDE;2-(PIPERAZIN-1-YL)ACET-N-(3-PYRIDYL)AMIDE TRIHYDROCHLORIDE;2-piperazin-1-yl-N-pyridin-3-ylacetamide trihydrochloride;2-piperazin-1-yl-N-pyridin-3-ylacetamide3HCl;2-(PIPERAZIN-1-YL)-ACETIC ACID N-PYRIDIN-3-YL-AMIDE X 3 HCL;2-(Piperazin-1-yl)-acetic acid N-(3-pyridyl)-amide x 3 HCl
• CAS NO: 667462-10-4
• Molecular Formula: C₁₁H₁₆N₄O
• Molecular Weight: 329.65
• Mol File: 667462-10-4.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 445.1°C at 760 mmHg
• Flash Point: 223°C
• Appearance: /
• Vapor Pressure: 4.06E-08mmHg at 25°C
• CAS DataBase Reference: 2-(PIPERAZIN-1-YL)-ACETIC ACID N-(3-PYRIDYL)-AMIDE 3 HCL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(PIPERAZIN-1-YL)-ACETIC ACID N-(3-PYRIDYL)-AMIDE 3 HCL(667462-10-4)
• EPA Substance Registry System: 2-(PIPERAZIN-1-YL)-ACETIC ACID N-(3-PYRIDYL)-AMIDE 3 HCL(667462-10-4)

Safety Data

• Hazard Codes: Xi
• Statements: 20/21/22
• Safety Statements: 22-36/37/39
• Hazardous Substances Data: 667462-10-4(Hazardous Substances Data)

Usage

General Description

"2-(piperazin-1-yl)-acetic acid N-(3-pyridyl)-amide 3 HCL" is a chemical compound that consists of a piperazine ring, acetic acid, and a pyridyl group. The compound is in the form of hydrochloride salt, indicated by the "3 HCL" in its name. It is commonly used in pharmaceutical research and development, particularly in the study of central nervous system disorders. 2-(PIPERAZIN-1-YL)-ACETIC ACID N-(3-PYRIDYL)-AMIDE 3 HCL is of interest due to its potential as a drug candidate, and its unique structure plays a role in its pharmacological properties. Further research on this compound may lead to the development of new medications targeting neurological disorders.

InChI:InChI=1/C11H16N4O.3ClH/c16-11(9-15-6-4-12-5-7-15)14-10-2-1-3-13-8-10;;;/h1-3,8,12H,4-7,9H2,(H,14,16);3*1H

Relevant articles and documents

ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES

The present invention relates to compound of formula I, II, III, or IV, and/or a pharmaceutical acceptable addition salt thereof and/or a stereoisomer thereof and/or a solvate thereof, Formulas (I), (II), (III) and (IV) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R11, and R12 are as defined in the claim 1 or as described in detail in the description of the invention, and to the use of said compounds to treat or prevent proliferative disorders and their use to manufacture a medicine to treat or prevent proliferative disorders, particularly cancer such as leukemia. The present invention also relates to pharmaceutical compositions of said compounds and the use of said pharmaceutical compositions to treat or prevent proliferative disorders. The present invention further relates to the use of said compounds as biologically active ingredients, more specifically as medicaments for the treatment of proliferative disorders and pathologic conditions such as, but not limited to, cancer such as leukemia.